Rapid start with bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as initial treatment in people with human immunodeficiency virus‐1 (HIV‐1): A systematic literature review of clinical and patient‐reported outcomes.
Saved in:
| Title: | Rapid start with bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as initial treatment in people with human immunodeficiency virus‐1 (HIV‐1): A systematic literature review of clinical and patient‐reported outcomes. |
|---|---|
| Authors: | Ghosn, Jade1,2, Chow, Jeremy3, Gandhi, Monica4, Górgolas, Miguel5, Al‐Hayani, Aws6, Tookes, Hansel7, Lee, Max8, Kaiser, Emily F.8, Malebranche, David9, Bognar, Fernando Alvarez9, Gandhi‐Patel, Bhumi9 bhumi.gandhipatel@gilead.com, Dai, Lili10 |
| Source: | HIV Medicine. Sep2025, Vol. 26 Issue 9, p1375-1394. 20p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14642662 |
|---|---|
| DOI: | 10.1111/hiv.70065 |
